CompletedNot Applicable

Laser Photocoagulation in Twin to Twin Transfusion Syndrome

United States1 participantsStarted 2010-04

Plain-language summary

Humanitarian use device (HUD): Use of the fetoscopy instrument sets for selective laser photocoagulation in the treatment of Twin to Twin Transfusion Syndrome (TTTS).

Who can participate

Age range16 Weeks – 27 Weeks

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The device will be used in multifetal pregnancies affected with twin-to-twin transfusion syndrome (TTTS) at less than 27 weeks of gestation Exclusion Criteria: * All other pregnancies not meeting inclusion criteria

What they're measuring

Laser ablation of placental anastomoses for treatment of severe TTTS and establishment of normalized blood flow between the fetal twins.

Timeframe: The device will be used in multifetal pregnancies affected with twin-to-twin transfusion syndrome (TTTS) at less than 27 weeks of gestation;procedure will last approx 1 hour

Trial details

NCT IDNCT02506049

SponsorUniversity of Tennessee

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-08-15

View on ClinicalTrials.gov More Twin to Twin Transfusion Syndrome trials